Abdelghani M, et al . Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open 2025;11:e004558. doi: 10.1136/rmdopen-2024–0 04 558 In this article, the abstract has been ...

If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...

Vikram Bhatt has opened up about battling an autoimmune condition called Axial spondyloarthritis. “I have an autoimmune ...

Why are Black patients are less likely to receive migraine treatment? Here's what you need to know about seeking adequate care.

Inclusion body myositis (IBM) is an inflammatory myopathy causing proximal and distal muscle weakness. IBM’s cause remains ...

Functional electrical stimulation (FES) is another effective treatment for muscle atrophy. It involves the use of electrical impulses to stimulate muscle contraction in affected muscles.

A regulatory decision is expected by October 2025. The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva ®) for the ...

Several known risk factors of Dermatomyositis (DM ... She is recognized for her contributions to advancing treatment options and understanding of these challenging conditions.

Dissociative identity disorder (DID) treatment involves a combination of different therapies, psychiatric medications, and coping strategies. Previously known as multiple personality disorder or split ...

Objectives To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis. Methods Patients with refractory inflammatory myositis treated with upadacitinib from ...

Juvenile dermatomyositis (JDM) is a rare autoimmune condition with ... activity using multiplexed RNA and protein single-cell sequencing applied to PBMCs from 4 treatment-naïve JDM (TN-JDM) subjects ...

The treatment, tenecteplase (sold as TNKase), delivers a single five-second IV shot, making it a faster, easier option. TNKase was initially approved in 2000 to reduce the risk of death from acute ...